Discovery of isoxazolyl-based inhibitors of Plasmodium falciparum cGMP-dependent protein kinase?

RSC Medicinal Chemistry Pub Date: 2019-12-16 DOI: 10.1039/C9MD00511K

Abstract

The cGMP-dependent protein kinase in Plasmodium falciparum (PfPKG) plays multiple roles in the life cycle of the parasite. As a result, this enzyme is a potential target for new antimalarial agents. Existing inhbitors, while potent and active in malaria models are not optimal. This communication describes initial optimization of a structurally distinct class of PfPKG inhibitors.

Graphical abstract: Discovery of isoxazolyl-based inhibitors of Plasmodium falciparum cGMP-dependent protein kinase
Recommended Literature